High density lipoprotein decreases β-amyloid toxicity in cortical cell culture
- 1 March 1997
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (5) , 1127-1130
- https://doi.org/10.1097/00001756-199703240-00013
Abstract
A hallmark of Alzheimer's disease (AD) is the extracellular deposition and accumulation of a 39–43 amino peptide, known as the amyloid beta (Aβ) protein, within the brain. It has been postulated that Aβ may in some way contribute directly to AD pathogenesis. The 4 allele of apolipoprotein E (apoE) is a major AD risk factor. Since both apoE and Aβ are components of lipoproteins in plasma and cerebrospinal fluid, we asked whether lipoproteins and apoE isoforms would modify the toxicity of Aβ (1–42) in cortical cell cultures. We show that high density lipoprotein with or without apoE reduces Aβ toxicity and that apoE in the absence of lipoproteins does not affect Aβ toxicity. These results suggest that interactions between Aβ and lipoproteins in the brain could influence AD pathogenesis.Keywords
This publication has 6 references indexed in Scilit:
- Human apolipoprotein E: the Alzheimer's disease connectionThe FASEB Journal, 1996
- Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptidesNature Genetics, 1996
- Apolipoprotein E and Alzheimer's DiseaseAnnual Review of Neuroscience, 1996
- Normal and Abnormal Biology of the beta-Amyloid Precursor ProteinAnnual Review of Neuroscience, 1994
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assayJournal of Neuroscience Methods, 1987